Edition:
India

People: argenx SE (ARGX.OQ)

ARGX.OQ on NASDAQ Stock Exchange Global Select Market

156.30USD
24 Feb 2020
Change (% chg)

$0.00 (+0.00%)
Prev Close
$156.30
Open
--
Day's High
--
Day's Low
--
Volume
210
Avg. Vol
54,801
52-wk High
$169.50
52-wk Low
$106.59

Castaldi, Eric 

Mr. Eric Castaldi has served as Chief Financial Officer of argenx SE since April 27, 2014. Eric Castaldi has served as the Company's Chief Financial Officer since April 2014 and served as a member of the Company's board of directors from July 2014 to April 26, 2017. Mr. Castaldi has 29 years of international financial executive management experience, including 20 years in the biopharmaceutical industry. From 1998 to 2014, Mr. Castaldi served as chief financial officer and a member of the executive committee of Nicox SA, a Euronext-listed biotechnology company. From 2008 to 2012, he served as a member of the board of directors and as chairman of the audit committee of Hybrigenics SA, a Euronext-listed French biopharmaceutical company specializing in oncology. Mr. Castaldi graduated with a degree in finance, accountancy and administration from Universite de Nice in 1986.

Basic Compensation

Total Annual Compensation, EUR 9,669,430
Restricted Stock Award, EUR --
Long-Term Incentive Plans, EUR --
All Other, EUR 62,335
Fiscal Year Total, EUR 9,731,770

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --